These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 18182224)

  • 1. Loss of glycinergic and GABAergic inhibition in chronic pain--contributions of inflammation and microglia.
    Zeilhofer HU
    Int Immunopharmacol; 2008 Feb; 8(2):182-7. PubMed ID: 18182224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroinflammation and Central Sensitization in Chronic and Widespread Pain.
    Ji RR; Nackley A; Huh Y; Terrando N; Maixner W
    Anesthesiology; 2018 Aug; 129(2):343-366. PubMed ID: 29462012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indicators of central sensitization in chronic neuropathic pain after spinal cord injury.
    Lütolf R; Rosner J; Curt A; Hubli M
    Eur J Pain; 2022 Nov; 26(10):2162-2175. PubMed ID: 36008094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Emerging Role of Quercetin in the Treatment of Chronic Pain.
    Liu C; Liu DQ; Tian YK; Mei W; Tian XB; Xu AJ; Zhou YQ
    Curr Neuropharmacol; 2022 Nov; 20(12):2346-2353. PubMed ID: 35959909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal Cord Injury and Loss of Cortical Inhibition.
    Benedetti B; Weidenhammer A; Reisinger M; Couillard-Despres S
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual PI3Kδ/γ Inhibitor Duvelisib Prevents Development of Neuropathic Pain in Model of Paclitaxel-Induced Peripheral Neuropathy.
    Adamek P; Heles M; Bhattacharyya A; Pontearso M; Slepicka J; Palecek J
    J Neurosci; 2022 Mar; 42(9):1864-1881. PubMed ID: 35042769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine signaling mediate pain transmission in the central nervous system.
    Zhou M; Wu J; Chang H; Fang Y; Zhang D; Guo Y
    Purinergic Signal; 2023 Mar; 19(1):245-254. PubMed ID: 35000074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Promise of Flavonoids to Combat Neuropathic Pain: From Molecular Mechanisms to Therapeutic Implications.
    Uddin MS; Mamun AA; Rahman MA; Kabir MT; Alkahtani S; Alanazi IS; Perveen A; Ashraf GM; Bin-Jumah MN; Abdel-Daim MM
    Front Neurosci; 2020; 14():478. PubMed ID: 32587501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMDA receptor activation induces long-term potentiation of glycine synapses.
    Kloc ML; Pradier B; Chirila AM; Kauer JA
    PLoS One; 2019; 14(9):e0222066. PubMed ID: 31498817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensory Modulation Disorder (SMD) and Pain: A New Perspective.
    Bar-Shalita T; Granovsky Y; Parush S; Weissman-Fogel I
    Front Integr Neurosci; 2019; 13():27. PubMed ID: 31379526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Riluzole induces LTD of spinal nociceptive signaling via postsynaptic GluR2 receptors.
    Zhang X; Gao Y; Wang Q; Du S; He X; Gu N; Lu Y
    J Pain Res; 2018; 11():2577-2586. PubMed ID: 30464577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional Microglia-Neuron Communication in Health and Disease.
    Szepesi Z; Manouchehrian O; Bachiller S; Deierborg T
    Front Cell Neurosci; 2018; 12():323. PubMed ID: 30319362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GlyT1 Inhibitor Bitopertin Ameliorates Allodynia and Hyperalgesia in Animal Models of Neuropathic and Inflammatory Pain.
    Armbruster A; Neumann E; Kötter V; Hermanns H; Werdehausen R; Eulenburg V
    Front Mol Neurosci; 2017; 10():438. PubMed ID: 29375301
    [No Abstract]   [Full Text] [Related]  

  • 14. Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics.
    Knezevic NN; Yekkirala A; Yaksh TL
    Anesth Analg; 2017 Nov; 125(5):1714-1732. PubMed ID: 29049116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Origins of Phantom Limb Pain.
    Kuffler DP
    Mol Neurobiol; 2018 Jan; 55(1):60-69. PubMed ID: 28921474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurosteroids are reduced in diabetic neuropathy and may be associated with the development of neuropathic pain.
    Humble SR
    F1000Res; 2016; 5():1923. PubMed ID: 28357038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and antihyperalgesic properties of the novel α2/3 preferring GABA
    Fischer BD; Schlitt RJ; Hamade BZ; Rehman S; Ernst M; Poe MM; Li G; Kodali R; Arnold LA; Cook JM
    Brain Res Bull; 2017 May; 131():62-69. PubMed ID: 28267561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Synaptic Integration of Forebrain GABAergic Precursors into the Adult Spinal Cord.
    Etlin A; Bráz JM; Kuhn JA; Wang X; Hamel KA; Llewellyn-Smith IJ; Basbaum AI
    J Neurosci; 2016 Nov; 36(46):11634-11645. PubMed ID: 27852772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Better Antiretroviral Central Nervous System Penetration is Not Associated with Reduced Chronic Pain in People Living with Human Immunodeficiency Virus.
    Robbins NM; Chaiklang K; Supparatpinyo K
    Antiinfect Agents; 2016; 14(1):38-46. PubMed ID: 27088075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and Future Issues in the Development of Spinal Agents for the Management of Pain.
    Yaksh TL; Fisher CJ; Hockman TM; Wiese AJ
    Curr Neuropharmacol; 2017; 15(2):232-259. PubMed ID: 26861470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.